Table: begin end state 1 19 cytoplasmic 20 41 transmembrane 42 46 non-cytoplasmic 47 66 transmembrane 67 85 cytoplasmic 86 105 transmembrane 106 124 non-cytoplasmic 125 144 transmembrane 145 153 cytoplasmic 154 176 transmembrane 177 195 non-cytoplasmic 196 220 transmembrane 221 240 cytoplasmic 241 261 transmembrane 262 287 non-cytoplasmic 288 309 transmembrane 310 342 cytoplasmic 343 363 transmembrane 364 369 non-cytoplasmic 370 389 transmembrane 390 408 cytoplasmic 409 432 transmembrane 433 437 non-cytoplasmic 438 455 transmembrane 456 472 cytoplasmic
Input: >Pf6N2E2_5633 MSGQNSHSGELKRGLKNRHIQLIALGGAIGTGLFLGSAGVLKSAGPSMILGYAICGFIAF MIMRQLGEMIVEEPVAGSFSHFAHKYWGGFAGFLSGWNCWILYILVGMSELTAVGKYIHY WAPDIPTWVSAAAFFILINVINLANVKVFGEAEFWFAIIKVVAIVGMIALGSYLLVSGHG GPQASVTNLWSHGGFFPNGVSGLVMAMAIIMFSFGGLEMLGFTAAEADKPKTVIPKAINQ VIYRILIFYIGALVVLLSLTPWDSLLSTLNASGDAYSGSPFVQVFSMLGSNTAAHILNFV VLTAALSVYNSGTYCNSRMLLGMAEQGDAPKVLSKIDKRGVPVRSILASAAVTLVAVLLN YLIPQHALELLMSLVVATLVINWAMISYSHFKFRQHMNQTHQTPLFKALWYPYGNYICLA FVVFILGVMLLIPGIQVSVYAIPVWVVFMAVCYWIKNKRSARQELAVAAAAK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server